CA2783306C - Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions - Google Patents
Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions Download PDFInfo
- Publication number
- CA2783306C CA2783306C CA2783306A CA2783306A CA2783306C CA 2783306 C CA2783306 C CA 2783306C CA 2783306 A CA2783306 A CA 2783306A CA 2783306 A CA2783306 A CA 2783306A CA 2783306 C CA2783306 C CA 2783306C
- Authority
- CA
- Canada
- Prior art keywords
- crown
- group
- groups
- crown ether
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014693A EP2332929A1 (en) | 2009-11-25 | 2009-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| EP09014693.7 | 2009-11-25 | ||
| PCT/EP2010/068224 WO2011064300A1 (en) | 2009-11-25 | 2010-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2783306A1 CA2783306A1 (en) | 2011-06-03 |
| CA2783306C true CA2783306C (en) | 2021-01-19 |
Family
ID=42101959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2783306A Active CA2783306C (en) | 2009-11-25 | 2010-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8624044B2 (https=) |
| EP (2) | EP2332929A1 (https=) |
| JP (1) | JP5848708B2 (https=) |
| CN (1) | CN102770421B (https=) |
| AU (1) | AU2010323101B2 (https=) |
| BR (1) | BR112012012539B8 (https=) |
| CA (1) | CA2783306C (https=) |
| ES (1) | ES2557916T3 (https=) |
| IL (1) | IL219966A (https=) |
| WO (1) | WO2011064300A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012012945A2 (pt) | 2009-11-25 | 2020-12-29 | Arisgen Sa | Composição de liberação mucosal, seu método de produção, complexo de peptídeo pré-formado, kit e uso de um agente ativo de peptídeo |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| EP3000811B1 (en) | 2014-09-24 | 2017-11-08 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Crown Ether Complexes and Methods for Poducing the Same |
| CN113195005B (zh) * | 2018-10-12 | 2023-07-21 | 国际先进加速器应用公司 | 包含放射性标记的grpr拮抗剂和表面活性剂的药物组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4113739A (en) * | 1974-01-28 | 1978-09-12 | The Dow Chemical Company | Process for preparation of (poly)cyclic polyethers |
| US4474963A (en) * | 1980-11-03 | 1984-10-02 | W. R. Grace & Co. | Crown ether compositions with sidearms affording enhanced cation binding |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| CA2230492C (en) | 1995-09-21 | 2009-05-26 | Genentech, Inc. | Human growth hormone variants |
| EP1905454A1 (en) * | 2006-09-27 | 2008-04-02 | Paolo Botti | Formulations comprising cyclic compounds |
-
2009
- 2009-11-25 EP EP09014693A patent/EP2332929A1/en not_active Withdrawn
-
2010
- 2010-11-25 EP EP10784504.2A patent/EP2504327B1/en not_active Not-in-force
- 2010-11-25 CN CN201080062354.9A patent/CN102770421B/zh not_active Expired - Fee Related
- 2010-11-25 JP JP2012540429A patent/JP5848708B2/ja not_active Expired - Fee Related
- 2010-11-25 ES ES10784504.2T patent/ES2557916T3/es active Active
- 2010-11-25 BR BR112012012539A patent/BR112012012539B8/pt not_active IP Right Cessation
- 2010-11-25 AU AU2010323101A patent/AU2010323101B2/en not_active Ceased
- 2010-11-25 CA CA2783306A patent/CA2783306C/en active Active
- 2010-11-25 WO PCT/EP2010/068224 patent/WO2011064300A1/en not_active Ceased
- 2010-11-25 US US13/511,837 patent/US8624044B2/en not_active Expired - Fee Related
-
2012
- 2012-05-23 IL IL219966A patent/IL219966A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012012539B8 (pt) | 2021-05-25 |
| IL219966A (en) | 2014-12-31 |
| BR112012012539B1 (pt) | 2021-05-11 |
| WO2011064300A1 (en) | 2011-06-03 |
| IL219966A0 (en) | 2012-07-31 |
| US8624044B2 (en) | 2014-01-07 |
| JP5848708B2 (ja) | 2016-01-27 |
| EP2332929A1 (en) | 2011-06-15 |
| ES2557916T3 (es) | 2016-01-29 |
| US20120301401A1 (en) | 2012-11-29 |
| AU2010323101B2 (en) | 2014-10-02 |
| AU2010323101A1 (en) | 2012-06-07 |
| BR112012012539A2 (pt) | 2016-05-03 |
| EP2504327A1 (en) | 2012-10-03 |
| EP2504327B1 (en) | 2015-07-29 |
| JP2013512221A (ja) | 2013-04-11 |
| CA2783306A1 (en) | 2011-06-03 |
| CN102770421A (zh) | 2012-11-07 |
| CN102770421B (zh) | 2014-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL220003A (en) | A drug release device | |
| AU2007302270B2 (en) | Formulations comprising cyclic compounds | |
| CA2783306C (en) | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions | |
| US20200040008A1 (en) | Dihydroartemisinin diploid derivative, pharmaceutical composition thereof, and application | |
| EP4431116A1 (en) | Epsilon-poly-l-lysine-based drug conjugate, intermediate thereof, and application thereof | |
| JP2019504839A (ja) | エリブリンの合成における中間体および関連する合成方法 | |
| AU2018350825B2 (en) | Macromolecular platform for targeting scavenger receptor A1 | |
| CN103347512A (zh) | 镇痛剂 | |
| JP6050332B2 (ja) | 薬物の粘膜投与 | |
| Guo et al. | Improved preparation of PEG-diortho ester-diacyl glycerol conjugates | |
| Lee et al. | A Star-PEGylation Strategy to Improve Testosterone Pharmacokinetics | |
| WO2023205625A2 (en) | 2,4 dnp and prodrugs thereof for treatment of pulmonary and autoimmune diseases | |
| KR20070071027A (ko) | 파클리탁셀 또는 이의 유도체를 포함하는 수용성 프로드럭화합물 및 이의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151125 |
|
| H11 | Ip right ceased following rejected request for revival |
Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED Effective date: 20250527 |
|
| H13 | Ip right lapsed |
Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE Effective date: 20251103 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251106 |